http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108120834-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-84 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-84 |
| filingDate | 2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108120834-B |
| titleOfInvention | Reagent composition for agglutinating variant cells |
| abstract | The invention provides a reagent composition for agglutinating variant cells, which comprises 1, 4-dimethylamino anthraquinone. The inventor unexpectedly finds that the 1, 4-dimethylamino anthraquinone has good effect of agglutinating the variant cells in the research process. The agglutinated variant cells can be observed to obtain information as an intermediate result, and the information can be used for early detection of tumors after statistical analysis and setting of judgment standards. |
| priorityDate | 2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.